Archives

06 Jun

Food, Health and Environmental Future Day: Biotechnology Drives Sustainability

On Tuesday, June 5, 2018, BIO hosted its Food, Health and Environmental Future Day at the 2018 BIO International Convention.

05 Jun

Last Chance to Save on What’s Hot in Seattle Biotech

There’s just one week left before Xconomy’s latest biotech event, “What’s Hot in Seattle Biotech.” Don’t let the clock run

05 Jun

DON’T MISS IT! EGVIA Workshop on EVs & their integration into the grid – State of play and challenges – 20 June 2018, BluePoint Brussels, 80 Bd. Auguste Reyers – 1030 Brussels

[Source: Research & Innovation] EGVIA (the European Green Vehicles Initiative Association) is organising #EVinthegrid2018 workshop, whose aim is to highligh

05 Jun

Robin Roberts Shares the Journey

When Good Morning America co-anchor Robin Roberts was diagnosed with cancer in 2007, she took her mother’s advice to “make

05 Jun

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Portola Pharmaceuticals (NASDAQ: PTLA) CEO Bill Lis is retiring from the South San Francisco, CA, drug developer. Lis will also

04 Jun

Aravive Seeks NASDAQ Perch Via Reverse Merger With Biotech Versartis

Houston biotech Aravive Biologics is going public through a reverse merger with Versartis, a Menlo Park, CA-based company whose lead

04 Jun

7th International Bioeconomy Conference – 6-7 July 2018, Halle (Saale), Germany

[Source: Research & Innovation] The ScienceCampus Halle and the BioEconomy Cluster Central Germany cordially invite you to the 7th International

04 Jun

Director of USPTO Addressed Intellectual Property Track Opening Plenary

(left to right) Associate Counsel and Director, Intellectual Property Policy Melissa Brand, USPTO Director Andrei Iancu, Deputy General Counsel and

02 Jun

Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning

Eli Lilly won regulatory approval for its rheumatoid arthritis drug Friday, nearly 14 months after the FDA rejected the once-daily

01 Jun

Drug Price Watchdog ICER Deems Amgen Migraine Drug “Cost-Effective”

As Amgen approached an FDA decision last month for its migraine-prevention treatment, concern mounted that the drug would come at